ライフサイエンスコーパス: gastric MALT lymphoma

1 d in lymphoepithelial lesions, a hallmark of gastric MALT lymphoma.

2 [p-ERK]) is associated with HP dependence of gastric MALT lymphoma.

3 ith the clinical management of patients with gastric MALT lymphoma.

4 n Helicobacter pylori-positive gastritis and gastric MALT lymphoma.

5 he splenic marginal zone in a single case of gastric MALT lymphoma.

6 a promising test for assessment of residual gastric MALT lymphomas after H pylori eradication.

7 ocation t(11;18)(q21,q21) is found in 30% of gastric MALT lymphomas and is associated with a failure

8 Apart from gastric MALT lymphoma, antibiotic therapies have been ad

9 of the depth of infiltration of the wall by gastric MALT lymphoma as measured by endoscopic ultrasou

10 8Ga]Pentixafor-PET for detection of residual gastric MALT lymphoma at follow-up were 97.0%, 95.0%, 10

11 ential involvement of the marginal zone when gastric MALT lymphomas disseminate to the spleen, which

12 The pathogenesis of gastric MALT lymphoma has been elucidated to a large deg

13 In gastric MALT lymphoma Helicobacter pylori is the most co

14 model to study pathogenesis and treatment of gastric MALT lymphoma in humans.

15 confirm a higher than expected incidence of gastric MALT lymphoma in immunosuppressed transplant rec

16 A subset of H. pylori-positive gastric MALT lymphomas, including infiltrative tumors, m

17 Gastric MALT lymphoma is a model malignancy for examinat

18 Among low-grade gastric MALT lymphoma, mutations were found in 3 of 11 t

19 ications have furthered the understanding of gastric MALT lymphoma pathogenesis, clinical behavior, a

20 c resonance imaging (MRI) examinations of 26 gastric MALT lymphoma patients, and 20 [68Ga]Pentixafor-

21 organism with antibiotics can be followed by gastric MALT lymphoma regression in most cases.

22 consensus for the treatment of patients with gastric MALT lymphoma requiring further treatment beyond

23 Early-stage, low-grade gastric MALT lymphoma that was associated with Helicobac

24 with its efficacy on high-grade transformed gastric MALT lymphomas, the DLBCL(MALT).

25 es, and medical records of six patients with gastric MALT lymphoma were retrospectively reviewed.

26 rds of four liver transplant recipients with gastric MALT lymphoma were reviewed.

27 our consecutive patients with stage I to IIE gastric MALT lymphoma who obtained a pathologic remissio

28 opsied at endoscopy demonstrated early-stage gastric MALT lymphoma with associated Helicobacter pylor

29 sed or relapsed Helicobacter pylori-negative gastric MALT lymphoma, with stage I-IV disease.